Psychiatry NewsGeneral NewsMyCare Insite November 4, 2022 New blood test drastically cutting waiting times in South London South London and Maudsley NHS Foundation Trust have rolled out a new blood test that… John Buckley Love0
Psychiatry NewsGeneral NewsMyCare Insite November 2, 2022 Point of care blood test cuts results wait from 10 days to six minutes ReStart and South London and Maudsley NHS Trust have joined forces to develop a new… John Buckley Love0
MyCare InsitePsychiatry News July 8, 2020 Saladax Biomedical launches clozapine test in the US after FDA grants market authorization Saladax Biomedical launches clozapine test in the US after FDA grants market authorization Saladax is… John Buckley Love0
MyCare InsitePsychiatry News June 27, 2020 HLS Therapeutics to Become Distributor of the Saladax MyCare™ Psychiatry Line including the Insite Point-of-Care Device and Antipsychotic Reagents The MyCare Insite is a point-of-care (POC) device that uses just a single drop of… John Buckley Love0
MyCare InsitePsychiatry News May 4, 2020 Saladax Biomedical to Collaborate with AVROBIO on New High-Speed Diagnostic Assay Used with Busulfan Conditioning to Enable Widespread Commercialization of AVROBIO’s Proprietary Platform Globally Fully automated immunoassay kit designed to simplify and streamline busulfan therapeutic drug monitoring (TDM), potentially… John Buckley Love1
MyCare InsitePsychiatry News May 1, 2020 Saladax Biomedical launches clozapine test in the US after FDA grants market authorization Saladax is advancing personalized medicine by providing psychiatrists with the first commercially available antipsychotic test… John Buckley Love1
MyCare InsitePsychiatry News October 24, 2019 Studies Feature Clinical Validations of Clozapine Point of Care Testing Using a Single Drop of Blood to Aid Psychiatrists in Better Treatment of Patients With Schizophrenia View the original press release at businesswire.com Bethlehem, PA – October 24, 2019 –Saladax Biomedical,… John Buckley Love1
MyCare InsitePsychiatry News September 5, 2019 Saladax Develops First-Ever Rapid Test for an Antipsychotic Drug Using a Single Drop of Blood to Aid Psychiatrists in the Treatment of Schizophrenia Bethlehem, PA – September 05, 2019 –Saladax Biomedical today announced that its MyCare Insite Clozapine Test… John Buckley Love1